Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dianne C. Whitfield currently holds 35,028 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dianne C. Whitfield has been a net seller of TARS stock. They have purchased $0 and sold $1.8M worth of shares.
Dianne C. Whitfield's most recent insider trade was on Mar 19, 2026, when they sold 4,174 shares at $67.00 per share.
Dianne C. Whitfield serves as Executive at Tarsus Pharmaceuticals, Inc. (TARS). They have executed 23 insider transactions totaling $1.8M over their tenure at the company.
Dianne C. Whitfield holds the position of Executive at Tarsus Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Dianne C. Whitfield has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Dianne C. Whitfield was on Dec 16, 2025, when they sold $592.5K worth of TARS shares. This transaction involved 7,397 shares at $80.10 per share.
Dianne C. Whitfield currently owns 35,028 shares of Tarsus Pharmaceuticals, Inc. (TARS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dianne C. Whitfield's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dianne C. Whitfield has 23 Form 4 filings on record as an insider at Tarsus Pharmaceuticals, Inc..
Set alerts for Dianne C. Whitfield and 40,000+ other insiders.